Delivery Order SPE2DB20D1109-SPE2DB25FP49G
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,537.97 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract represents a single delivery order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $13,844.92 delivery order to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on July 24, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of the company's established role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $9,265.30 for Enbrel 50 mg/mL SureClick auto-injectors on July 30, 2025, with an ultimate completion date of July 31, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,183.90 to AmerisourceBergen Drug Corp for the supply of Enbrel 50 mg/ml SureClick auto-injectors. This firm fixed-price delivery order, issued on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major...
- The Defense Logistics Agency awarded a $67,548.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 mg/mL SureClick auto-injectors. The contract, which was competitively awarded with no set-aside designation, was executed on August 13, 2025, with an ultimate completion date of August 14, 2025. Performance will be conducted at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $22,877.90 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors. The contract, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a firm fixed-price procurement with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly serving...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,592.67 to AmerisourceBergen Drug Corp for the supply of ENBREL 50 mg/ml SureClick auto-injectors. This non-set-aside, competitively awarded contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and reflects a firm fixed price arrangement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $122,324.90 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pharmaceutical products, with an ultimate completion date of July 29, 2025. This non-set-aside competitive award was issued on July 28, 2025, for delivery to the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency (DLA) awarded a $28,810.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors. The contract, which was awarded on July 21, 2025, with a completion date of July 22, 2025, represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order valued at $14,972.50 to AmerisourceBergen Drug Corp for ENBREL 50 mg/ml SureClick auto-injectors, with performance in Conshohocken, Pennsylvania and an ultimate completion date of August 12, 2025. This competitive award, issued on August 11, 2025, utilizes firm fixed pricing and carries no set-aside designation. The delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB25FP49GDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injectors valued at $9,253.56 on July 30, 2025, with a completion date of July 31, 2025. This firm fixed price, non-competitive delivery order represents pharmaceutical procurement for military healthcare needs and is being fulfilled from AmerisourceBergen's place of performance in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. ENBREL is a biologic immunosuppressant used to treat autoimmune conditions including rheumatoid arthritis, making this order consistent with AmerisourceBergen's extensive portfolio of specialty medications and brand-name pharmaceuticals supplied to military healthcare programs. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen routinely fulfills both small-value transactions and substantial orders for therapeutic products ranging from specialty biologics to vaccines and medical devices, demonstrating the company's capability to support diverse military healthcare requirements through competitive federal procurement processes.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.3k | 7/30/25 |